QuidelOrtho Corp
QDEL
Company Profile
Business description
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Contact
9975 Summers Ridge Road
San DiegoCA92121
USAT: +1 858 552-1100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
6,600
Stocks News & Analysis
stocks
Potential moonshot investment at ASX tech leader
Investors may be over optimistic about the prospects for a new revenue source.
stocks
These ASX earnings season dogs may have fallen too far
The longer term outlook for these moated companies looks far brighter than markets seem to be giving them credit for.
stocks
Our view of the supermarkets after earnings
Are the shares of two of Australia’s best known brands attractive?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,478.80 | 74.90 | 0.89% |
| CAC 40 | 8,166.98 | 55.35 | 0.68% |
| DAX 40 | 22,798.22 | 246.79 | 1.09% |
| Dow JONES (US) | 43,840.91 | 601.41 | 1.39% |
| FTSE 100 | 8,851.17 | 41.43 | 0.47% |
| HKSE | 23,006.27 | 64.95 | 0.28% |
| NASDAQ | 18,847.28 | 302.86 | 1.63% |
| Nikkei 225 | 37,785.47 | 629.97 | 1.70% |
| NZX 50 Index | 12,550.05 | 51.37 | -0.41% |
| S&P 500 | 5,954.50 | 92.93 | 1.59% |
| S&P/ASX 200 | 8,245.70 | 73.30 | 0.90% |
| SSE Composite Index | 3,316.93 | 3.97 | -0.12% |